PAMR1
Inactive serine protease PAMR1
Also known as: DKFZP586H2123, PAMR1_HUMAN, RAMP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UXH9
- Gene
- PAMR1
- Ensembl
- ENSG00000149090
- Chromosome
- 11
- Canonical length
- 720 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to enable calcium ion binding activity and serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
720 residues, UniProt reviewed canonical sequence.
>Q6UXH9|PAMR1
1 MELGCWTQLG LTFLQLLLIS SLPREYTVIN EACPGAEWNI MCRECCEYDQ IECVCPGKRE
61 VVGYTIPCCR NEENECDSCL IHPGCTIFEN CKSCRNGSWG GTLDDFYVKG FYCAECRAGW
121 YGGDCMRCGQ VLRAPKGQIL LESYPLNAHC EWTIHAKPGF VIQLRFVMLS LEFDYMCQYD
181 YVEVRDGDNR DGQIIKRVCG NERPAPIQSI GSSLHVLFHS DGSKNFDGFH AIYEEITACS
241 SSPCFHDGTC VLDKAGSYKC ACLAGYTGQR CENLLEERNC SDPGGPVNGY QKITGGPGLI
301 NGRHAKIGTV VSFFCNNSYV LSGNEKRTCQ QNGEWSGKQP ICIKACREPK ISDLVRRRVL
361 PMQVQSRETP LHQLYSAAFS KQKLQSAPTK KPALPFGDLP MGYQHLHTQL QYECISPFYR
421 RLGSSRRTCL RTGKWSGRAP SCIPICGKIE NITAPKTQGL RWPWQAAIYR RTSGVHDGSL
481 HKGAWFLVCS GALVNERTVV VAAHCVTDLG KVTMIKTADL KVVLGKFYRD DDRDEKTIQS
541 LQISAIILHP NYDPILLDAD IAILKLLDKA RISTRVQPIC LAASRDLSTS FQESHITVAG
601 WNVLADVRSP GFKNDTLRSG VVSVVDSLLC EEQHEDHGIP VSVTDNMFCA SWEPTAPSDI
661 CTAETGGIAA VSFPGRASPE PRWHLMGLVS WSYDKTCSHR LSTAFTKVLP FKDWIERNMKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAMR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- cervix: 56 nTPM
- endometrium: 55 nTPM
- placenta: 53 nTPM
- vagina: 41 nTPM
- adipose tissue: 32 nTPM
- urinary bladder: 28 nTPM
Single-cell type
- ependymal cells: 667 nCPM
- astrocytes: 636 nCPM
- adrenal medulla cells: 277 nCPM
- breast myoepithelial cells: 209 nCPM
- fibro-adipogenic progenitors: 144 nCPM
- salivary myoepithelial cells: 143 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- spinal cord: 73 nTPM
- medulla oblongata: 57 nTPM
- white matter: 56 nTPM
- midbrain: 52 nTPM
- thalamus: 48 nTPM
- basal ganglia: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.46
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sushi/SCR/CCP domain
- EGF-like domain
- CUB domain
- Serine proteases, trypsin domain
- Peptidase S1A, chymotrypsin family
- EGF-like calcium-binding domain
- Peptidase S1, PA clan
- Spermadhesin, CUB domain superfamily
- Sushi/SCR/CCP superfamily
- Serine Protease S1 Domain-Containing Protein
- EGF-like domain
- Sushi repeat (SCR repeat)
- Trypsin
- CUB domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAMR1 as an antibody target. Whether an autoantibody or antibody against PAMR1 could matter depends on whether native PAMR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAMR1 is annotated as secreted, so native PAMR1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PAMR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...